Atlas Trials

A Bioequivalence Study of Montelukast From Asmakast 10mg Tabs (Sandoz, Egypt) & Singulair 10mg Tabs (Merck)

Clinical trial NCT02480049 · COMPLETED

Trial details

NCT number
NCT02480049
Sponsor
Genuine Research Center, Egypt
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2014-08-01
Primary completion
2014-08-01
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.